LakeShore Biopharma Co., Ltd (LSB)
USD 1.57
(-3.99%)
USD 1.57
(-3.99%)
| Breakdown | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Revenue | 573.41 Million | 687.2 Million | 502.94 Million | 257.01 Million |
| Cost of Revenue | 117.68 Million | 153.36 Million | 117.06 Million | 59.65 Million |
| Gross Profit | 455.72 Million | 533.84 Million | 385.88 Million | 197.35 Million |
| Operating Expenses | 901.56 Million | 647.15 Million | 549.17 Thousand | 319.67 Million |
| Selling, General and Administrative Expenses | 428.09 Million | 333.32 Million | 549.17 Thousand | 208.32 Million |
| Research and Development Expenses | 302.8 Million | 318.7 Million | 211.22 Million | 94.38 Million |
| Other Expenses | 170.66 Million | -199.45 Thousand | -2.41 Million | -22.36 Million |
| Cost and Expenses | 1.01 Billion | 800.51 Million | 549.17 Thousand | 379.33 Million |
| Operating Income | -445.83 Million | -139.38 Million | -549.18 Thousand | -125.84 Million |
| Interest Expense | 44.34 Million | 30.85 Million | 2.71 Million | 29.68 Million |
| Income Tax Expense | -21.72 Million | 1.13 Million | 4.93 Million | 17.45 Million |
| Earnings before Tax | -455.19 Million | -144.34 Million | -545.72 Thousand | -174.37 Million |
| Net Income | -433.46 Million | -145.47 Million | -545.72 Thousand | -191.82 Million |
| Earnings Per Share Basic | -4.05 | -1.88 | -0.02 | -6.67 |
| Earnings Per Share Diluted | -4.05 | -1.88 | -0.02 | -6.67 |
| Weighted Average Shares Outstanding | 106.92 Million | 77.42 Million | 29.5 Million | 28.75 Million |
| Weighted Average Shares Outstanding (Diluted) | 106.92 Million | 77.42 Million | 29.5 Million | 28.75 Million |
| Gross Margin | 0.79 | 0.78 | 0.77 | 0.77 |
| EBIT Margin | -0.64 | -0.11 | -0.00 | -0.45 |
| Profit Margin | -0.76 | -0.21 | -0.00 | -0.75 |
| EBITDA | -368.66 Million | -76.8 Million | -67.19 Million | -116.77 Million |
| Earnings Before Tax Margin | -0.78 | -0.20 | -0.00 | -0.49 |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 573.41 Million | 18.74 Million | 23.81 Million | 96.81 Million | 176.27 Million | 15.43 Million |
| Cost of Revenue | 117.68 Million | 13.98 Million | 4.92 Million | 17.5 Million | 34.68 Million | 3.07 Million |
| Gross Profit | 455.72 Million | 4.75 Million | 18.88 Million | 79.31 Million | 141.59 Million | 12.35 Million |
| Operating Expenses | 723.43 Million | 29.81 Million | 30.76 Million | 179.36 Million | 210.17 Million | 23.05 Million |
| Selling, General and Administrative Expenses | - | 8.66 Million | 21.13 Million | 114.3 Million | 111 Million | 6.72 Million |
| Research and Development Expenses | - | 8.05 Million | 9.63 Million | 78.21 Million | 100.64 Million | 14.11 Million |
| Other Expenses | 9.81 Million | 13.09 Million | - | -381.92 Thousand | -213 Thousand | 2.21 Million |
| Cost and Expenses | 841.12 Million | 43.79 Million | 35.69 Million | 196.86 Million | 244.85 Million | 26.12 Million |
| Operating Income | -445.83 Million | -25.05 Million | -11.87 Million | -113.2 Million | -70.05 Million | -10.69 Million |
| Interest Expense | 44.34 Million | 3.26 Million | 1.17 Million | 6.89 Million | 8.02 Million | - |
| Income Tax Expense | -21.72 Million | 1.86 Million | -1.05 Million | -234.35 Thousand | -586 Thousand | 87 Thousand |
| Earnings before Tax | -455.19 Million | -26.95 Million | -12.36 Million | -105.21 Million | -70.12 Million | -16.24 Million |
| Net Income | -433.46 Million | -25.09 Million | -11.31 Million | -104.98 Million | -69.54 Million | -16.15 Million |
| Earnings Per Share Basic | - | -1.69 | -0.12 | -1.13 | -0.75 | -1.92 |
| Earnings Per Share Diluted | - | -1.69 | -0.12 | -1.13 | -0.75 | -2.62 |
| Weighted Average Shares Outstanding | 106.92 Million | 14.85 Million | 93.05 Million | 93.05 Million | 93.05 Million | 8.43 Million |
| Weighted Average Shares Outstanding (Diluted) | 106.92 Million | 14.85 Million | 93.05 Million | 93.05 Million | 93.05 Million | 6.17 Million |
| Gross Margin | 0.79 | 0.25 | 0.79 | 0.82 | 0.80 | 0.80 |
| EBIT Margin | - | -0.61 | -0.50 | -1.02 | -0.39 | -0.52 |
| Profit Margin | -0.76 | -1.34 | -0.48 | -1.08 | -0.39 | -1.05 |
| EBITDA | - | -11.44 Million | -11.87 Million | -98.47 Million | -68.79 Million | -8.09 Million |
| Earnings Before Tax Margin | -0.78 | -1.34 | -0.50 | -1.17 | -0.40 | -0.69 |
DFM
CAIXY
001560
4893
AIW
0A23